Francesca Palone
Schede primarie
Found 23 results
Filtri: Autore is Francesca Palone
Identificazione di Biomarcatori Fecali per la Diagnosi e la Prognosi della Malattia di Alzheimer,
, 02/2025, Number 102025000001602, Italia, (2025)
Inhibition of intestinal inflammation and fibrosis by Scutellaria Baicalensis georgi and Boswellia serrata in human epithelial cells and fibroblasts,
, Immunity, Inflammation and Disease, Volume 12, Number 10, (2024)
PARP1 inactivation increases regulatory T / Th17 cell proportion in intestinal inflammation. Role of HMGB1,
, Immunology Letters, Volume 270, (2024)
Characterization of Early and Late Damage in a Mouse Model of Pelvic Radiation Disease,
, International Journal of Molecular Sciences, Volume 24, Number 10, (2023)
PARP1 Activation Induces HMGB1 Secretion Promoting Intestinal Inflammation in Mice and Human Intestinal Organoids,
, International Journal of Molecular Sciences, Volume 24, Number 8, (2023)
Innovative method to grow the probiotic Lactobacillus reuteri in the omega3-rich microalga Isochrysis galbana,
, Scientific Reports, Volume 12, Number 1, (2022)
Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease,
, Journal of Crohn's and Colitis, Jun-08-2024, Volume 17, Issue 1, Number 1, p.92 - 102, (2022)
ZNF281 Promotes Colon Fibroblast Activation in TGFβ1-Induced Gut Fibrosis,
, International Journal of Molecular Sciences, Volume 23, Number 18, (2022)
Colonic inflammation accelerates the progression of liver disease: A protective role of dipotassium glycyrrhizate,
, Digestive and Liver Disease, Jan-12-2021, Volume 54, Number 8, p.1084-1093, (2021)
Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates,
, Frontiers in Pediatrics, Volume 9, (2021)
Intestinal Inflammation Alters the Expression of Hepatic Bile Acid Receptors Causing Liver Impairment,
, Journal of Pediatric Gastroenterology & Nutrition, Jan-01-2020, Volume 71, Issue 2, Number 2, p.189 - 196, (2020)
Dipotassium Glycyrrhizate Improves Intestinal Mucosal Healing by Modulating Extracellular Matrix Remodeling Genes and Restoring Epithelial Barrier Functions,
, Frontiers in Immunology, Feb-04-2021, Volume 10, Number APR, (2019)
Functional analysis of gut microbiota and immunoinflammation in children with autism spectrum disorders,
, Digestive and Liver Disease, Volume 51, Number 10, p.1366-1374, (2019)
Low Dose of Dipotassium Glycyrrhizate Counteracts Atherosclerosis Progression in Apoe-/- Female Mice,
, Journal of Vascular Research, Volume 56, Number 5, p.267-270, (2019)
Faecal high mobility group box 1 in children with celiac disease: A pilot study,
, Digestive and Liver Disease, Volume 50, Number 9, p.916-919, (2018)
P075 Lactobacillus reuteri cultured in green unicellular microalga Isochrysis rich in omega-3 provides a novel tool to limit AIEC growth and reduce gut inflammation,
, Digestive and Liver Disease, Volume 50, Number 4, p.e385, (2018)
Transcription Factor ZNF281: A Novel Player in Intestinal Inflammation and Fibrosis,
, Frontiers in immunology, Volume 9, p.2907, (2018)
RIP3, a regulator of necroptosis, promotes inflammation by increasing cytokine and inflammasome molecule levels as well as altering membrane permeability in intestinal epithelial cells,
, Digestive and Liver Disease, Volume 49, Number 4, p.e264, (2017)
Fecal HMGB1 reveals microscopic inflammation in adult and pediatric patients with inflammatory bowel disease in clinical and endoscopic remission,
, Inflammatory Bowel Diseases, Volume 22, Number 12, p.2886-2893, (2016)
Omega 3, Lactobacillus reuteri and vitamin D collaborate in diminishing gut inflammation,
, Digestive and Liver Disease, Volume 48, p.e267, (2016)
Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation,
, Biochemical Pharmacology, Volume 97, Number 3, p.292-299, (2015)
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease,
, Inflammatory Bowel Diseases, Volume 20, Number 8, p.1448-1457, (2014)
Tu1622 Glycyrrhizin Decreases HMGB1 Release and Is Effective for the Treatment of Chemical-Induced Murine Colitis,
, Gastroenterology, Volume 5, Number 144, p.S–808, (2013)
